As. Salhab et al., FETOPLACENTAL GROWTH AND PLACENTAL PROTEIN-SYNTHESIS IN RATS AFTER CHRONIC MATERNAL COCAINE ADMINISTRATION, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 392-398
This study evaluated the effects of chronic exposure to cocaine during
pregnancy on the morphology and function of the placenta. Pregnant ra
ts received either 45 or 60 mg/kg of cocaine hydrochloride by i.p. inj
ection as a divided daily dose on days 8 to 18 of gestation. The mater
nal weight gain decreased by 20% to 24% (P <.05) in the two cocaine tr
eatment groups, whereas the placental weight was not significantly alt
ered. Fetal growth showed a dose-related decrease in the 45- and 60-mg
/kg cocaine treatment groups; fetal body weights and length were signi
ficantly decreased by 5% to 10%. The plasma levels of cocaine were 0.7
9 and 1.09 mu g/ml in the 45-and 60-mg treatment dose groups, respecti
vely; the level in the fetal plasma was 3-fold higher in the latter gr
oup. Placental tissue explants were cultured in the presence of [S-35]
-methionine to investigate whether cocaine exposure altered placental
protein synthesis. Secreted proteins were analyzed by polyacrylamide g
el electrophoresis followed by fluorography or by western blotting and
immunostaining with antibodies to placental prolactin-like proteins-B
and -C and growth hormone-related protein-1. The data showed that the
re were no quantitative or qualitative changes in placental peptide ho
rmone secretion as a result of the cocaine treatment. These data indic
ate that chronic cocaine exposure in the pregnant rat is associated wi
th fetal growth retardation in the absence of alterations in placental
morphology or secretory protein synthesis.